Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Mingozzi

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2021
Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndromeMartina Parrini, Shovan Naskar, Micol Alberti, et al.
Gene Therapy|January 18, 2021
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factorElena Barbon, Charlotte Kawecki, Solenne Marmier, et al.
Molecular Therapy. Methods & Clinical Development|October 8, 2015
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypesDaniel J Hui, Shyrie C Edmonson, Gregory M Podsakoff, et al.
Thrombosis and Haemostasis|October 30, 2019
Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B MiceSandra Le Quellec, Allison P Dane, Elena Barbon, et al.
JCI Insight|June 7, 2019
Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunityLaurent Bartolo, Stéphanie Li Chung Tong, Pascal Chappert, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector TransductionZachary Fitzpatrick, Christian Leborgne, Elena Barbon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2019
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's DiseaseStefano Espinoza, Margherita Scarpato, Devid Damiani, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Cellular Immunology|March 25, 2018
Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patientsChristian Leborgne, Virginie Latournerie, Sylvie Boutin, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2021
Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndromeMartina Parrini, Shovan Naskar, Micol Alberti, et al.
Gene Therapy|January 18, 2021
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factorElena Barbon, Charlotte Kawecki, Solenne Marmier, et al.
Molecular Therapy. Methods & Clinical Development|October 8, 2015
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypesDaniel J Hui, Shyrie C Edmonson, Gregory M Podsakoff, et al.
Thrombosis and Haemostasis|October 30, 2019
Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B MiceSandra Le Quellec, Allison P Dane, Elena Barbon, et al.
JCI Insight|June 7, 2019
Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunityLaurent Bartolo, Stéphanie Li Chung Tong, Pascal Chappert, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector TransductionZachary Fitzpatrick, Christian Leborgne, Elena Barbon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2019
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's DiseaseStefano Espinoza, Margherita Scarpato, Devid Damiani, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Cellular Immunology|March 25, 2018
Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patientsChristian Leborgne, Virginie Latournerie, Sylvie Boutin, et al.
Pageof 14